Alexandru Iordache

Carol Davila University of Medicine and Pharmacy

Papers

1

Total Citations

2

H-Index

1

About

Alexandru Iordache is a leading urologic oncologist whose research centers on optimizing surgical outcomes for complex renal cell carcinoma (RCC), particularly in patients with solitary kidneys. His major contribution lies in synthesizing evidence for partial nephrectomy in this high-risk population, where preserving renal function is paramount. In his highly cited 2025 non-systematic review, Iordache systematically evaluates evolving surgical strategies—from open and laparoscopic approaches to robot-assisted partial nephrectomy (RAPN)—demonstrating how technique refinement can improve oncologic control while minimizing complications. His work has garnered significant attention, with early citations reflecting its immediate impact on clinical practice. Iordache’s research bridges the gap between emerging technology and patient-centered outcomes, offering urologists a practical framework for decision-making in challenging cases. By highlighting the nuances of tumor management in solitary kidneys, he has advanced the field’s understanding of nephron-sparing surgery, earning recognition as a key voice in modern urologic oncology. His ongoing contributions continue to shape guidelines for treating RCC in anatomically vulnerable patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Optimizing outcomes of partial nephrectomy in patients with tumors in solitary kidneys: a non-systematic review
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Carol Davila University of Medicine and Pharmacy

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago